InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,826.40
(
0.94%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
-0.64%
)
Bitcoin
56,565.94
(
-0.73%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17455
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: mouton29 post# 5130

Tuesday, 11/27/2007 9:29:29 PM

Tuesday, November 27, 2007 9:29:29 PM

Post# of 12660
RE : and how expensive can it be to keep track...

I don't think it's a cost issue. If it is strongly believed that the treatment has no effect on events after T months, then continuing the analysis past then would only add confounding factors w/o providing theoretical benifit.

Additionally, the significance of other follow treatments will further add randomness, which I think must drive the power of the trial down.

This is OT, as we all (longs/supporters/chearleaders/whatever) believe that Provenge does provide an extended survival benifit.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up